rs1131296

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_004369.4(COL6A3):​c.9206C>T​(p.Thr3069Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.385 in 1,612,638 control chromosomes in the GnomAD database, including 121,469 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 10885 hom., cov: 32)
Exomes 𝑓: 0.39 ( 110584 hom. )

Consequence

COL6A3
NM_004369.4 missense

Scores

18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:15

Conservation

PhyloP100: 0.655

Publications

34 publications found
Variant links:
Genes affected
COL6A3 (HGNC:2213): (collagen type VI alpha 3 chain) This gene encodes the alpha-3 chain, one of the three alpha chains of type VI collagen, a beaded filament collagen found in most connective tissues. The alpha-3 chain of type VI collagen is much larger than the alpha-1 and -2 chains. This difference in size is largely due to an increase in the number of subdomains, similar to von Willebrand Factor type A domains, that are found in the amino terminal globular domain of all the alpha chains. These domains have been shown to bind extracellular matrix proteins, an interaction that explains the importance of this collagen in organizing matrix components. Mutations in the type VI collagen genes are associated with Bethlem myopathy, a rare autosomal dominant proximal myopathy with early childhood onset. Mutations in this gene are also a cause of Ullrich congenital muscular dystrophy, also referred to as Ullrich scleroatonic muscular dystrophy, an autosomal recessive congenital myopathy that is more severe than Bethlem myopathy. Multiple transcript variants have been identified, but the full-length nature of only some of these variants has been described. [provided by RefSeq, Jun 2009]
COL6A3 Gene-Disease associations (from GenCC):
  • Bethlem myopathy 1A
    Inheritance: AD, AR, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Ambry Genetics
  • collagen 6-related myopathy
    Inheritance: AD, AR Classification: DEFINITIVE Submitted by: ClinGen
  • Ullrich congenital muscular dystrophy 1C
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • dystonia 27
    Inheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED, NO_KNOWN Submitted by: Illumina, Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
  • Ullrich congenital muscular dystrophy 1A
    Inheritance: AR, AD, SD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp
  • Bethlem myopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Ullrich congenital muscular dystrophy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=7.188022E-4).
BP6
Variant 2-237334649-G-A is Benign according to our data. Variant chr2-237334649-G-A is described in ClinVar as Benign. ClinVar VariationId is 95018.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.463 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
COL6A3NM_004369.4 linkc.9206C>T p.Thr3069Ile missense_variant Exon 41 of 44 ENST00000295550.9 NP_004360.2 P12111-1D9ZGF2Q8N4Z1Q63HQ4
COL6A3NM_057167.4 linkc.8588C>T p.Thr2863Ile missense_variant Exon 40 of 43 NP_476508.2 P12111-2Q8N4Z1Q63HQ4
COL6A3NM_057166.5 linkc.7385C>T p.Thr2462Ile missense_variant Exon 38 of 41 NP_476507.3 P12111-4B7ZW00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
COL6A3ENST00000295550.9 linkc.9206C>T p.Thr3069Ile missense_variant Exon 41 of 44 1 NM_004369.4 ENSP00000295550.4 P12111-1

Frequencies

GnomAD3 genomes
AF:
0.370
AC:
56226
AN:
151894
Hom.:
10891
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.282
Gnomad AMI
AF:
0.523
Gnomad AMR
AF:
0.351
Gnomad ASJ
AF:
0.397
Gnomad EAS
AF:
0.478
Gnomad SAS
AF:
0.328
Gnomad FIN
AF:
0.504
Gnomad MID
AF:
0.446
Gnomad NFE
AF:
0.397
Gnomad OTH
AF:
0.389
GnomAD2 exomes
AF:
0.385
AC:
96600
AN:
250848
AF XY:
0.388
show subpopulations
Gnomad AFR exome
AF:
0.275
Gnomad AMR exome
AF:
0.311
Gnomad ASJ exome
AF:
0.390
Gnomad EAS exome
AF:
0.476
Gnomad FIN exome
AF:
0.493
Gnomad NFE exome
AF:
0.402
Gnomad OTH exome
AF:
0.409
GnomAD4 exome
AF:
0.386
AC:
564375
AN:
1460626
Hom.:
110584
Cov.:
50
AF XY:
0.386
AC XY:
280206
AN XY:
726618
show subpopulations
African (AFR)
AF:
0.278
AC:
9294
AN:
33452
American (AMR)
AF:
0.316
AC:
14125
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
0.396
AC:
10342
AN:
26128
East Asian (EAS)
AF:
0.505
AC:
20048
AN:
39698
South Asian (SAS)
AF:
0.328
AC:
28298
AN:
86200
European-Finnish (FIN)
AF:
0.487
AC:
25982
AN:
53404
Middle Eastern (MID)
AF:
0.429
AC:
2266
AN:
5282
European-Non Finnish (NFE)
AF:
0.388
AC:
430785
AN:
1111466
Other (OTH)
AF:
0.385
AC:
23235
AN:
60306
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.469
Heterozygous variant carriers
0
18273
36546
54818
73091
91364
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
13250
26500
39750
53000
66250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.370
AC:
56228
AN:
152012
Hom.:
10885
Cov.:
32
AF XY:
0.375
AC XY:
27871
AN XY:
74290
show subpopulations
African (AFR)
AF:
0.282
AC:
11695
AN:
41464
American (AMR)
AF:
0.351
AC:
5361
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.397
AC:
1380
AN:
3472
East Asian (EAS)
AF:
0.479
AC:
2474
AN:
5170
South Asian (SAS)
AF:
0.328
AC:
1574
AN:
4798
European-Finnish (FIN)
AF:
0.504
AC:
5307
AN:
10538
Middle Eastern (MID)
AF:
0.456
AC:
134
AN:
294
European-Non Finnish (NFE)
AF:
0.397
AC:
27007
AN:
67966
Other (OTH)
AF:
0.388
AC:
819
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1820
3640
5460
7280
9100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
536
1072
1608
2144
2680
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.390
Hom.:
40093
Bravo
AF:
0.355
TwinsUK
AF:
0.391
AC:
1449
ALSPAC
AF:
0.385
AC:
1484
ESP6500AA
AF:
0.285
AC:
1256
ESP6500EA
AF:
0.402
AC:
3456
ExAC
AF:
0.388
AC:
47094
Asia WGS
AF:
0.385
AC:
1337
AN:
3478
EpiCase
AF:
0.398
EpiControl
AF:
0.402

ClinVar

Significance: Benign
Submissions summary: Benign:15
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:9
-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 14, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 31, 2024
Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is classified as Benign based on local population frequency. This variant was detected in 45% of patients studied in a panel designed for Epileptic and Developmental Encephalopathy, Progressive Myoclonus Epilepsy and Abnormal Movements and Neurodegeneration with brain iron accumulation. Number of patients: 42. Only high quality variants are reported. -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jul 09, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Aug 15, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bethlem myopathy 1A Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dystonia 27 Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Collagen 6-related myopathy Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Ullrich congenital muscular dystrophy 1A Benign:1
Jul 30, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.076
BayesDel_addAF
Benign
-0.76
T
BayesDel_noAF
Benign
-0.72
CADD
Benign
9.9
DANN
Benign
0.88
DEOGEN2
Benign
0.17
.;T;.;T;.
Eigen
Benign
-0.78
Eigen_PC
Benign
-0.70
FATHMM_MKL
Benign
0.48
N
LIST_S2
Benign
0.56
T;T;T;T;.
MetaRNN
Benign
0.00072
T;T;T;T;T
MetaSVM
Benign
-0.90
T
MutationAssessor
Benign
0.20
.;N;.;.;.
PhyloP100
0.66
PrimateAI
Benign
0.37
T
PROVEAN
Benign
-1.3
N;N;N;.;N
REVEL
Benign
0.034
Sift
Benign
0.26
T;T;T;.;T
Sift4G
Benign
0.24
T;T;T;T;T
Polyphen
0.0030
B;B;.;.;B
Vest4
0.052
MPC
0.16
ClinPred
0.0070
T
GERP RS
-1.1
Varity_R
0.042
gMVP
0.52
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1131296; hg19: chr2-238243292; COSMIC: COSV55079237; COSMIC: COSV55079237; API